The abstracts of the CTAD are available in PDF format, you can download them on

this link

The abstracts of the ICFSR are available in PDF format, you can download them on this link

this link

The abstracts of the ICFSR are available in PDF format, you can download them on this link

this link

Page 32 of 102

Contents of the Journal of Frailty & Aging (JFA) vol. 8, n° 4, 2019

The Contents of the Journal of Frailty & Aging (JFA) vol. 8, n° 4, 2019 are available Biology of Frailty Relationship of physical frailty to phosphocreatine recovery in muscle after mild exercise stress in the oldest-old women. Varadhan, D.W. Russ, R.E…. Continue Reading →

Utilization of Observational Data as a Proxy Cohort for Comparison Purposes with Open-Label Study Results: An Example from Alzheimer’s Disease

Randomized placebo-controlled trials in the development of disease-modifying treatments for Alzheimer’s disease are typically of short duration (12–18 months), and health economic modeling requires extrapolation of treatment effects beyond the trial period. (1) Reed, C., Happich, M., Raskin, J. et al…. Continue Reading →

Combination Therapy for Alzheimer’s Disease: Perspectives of the EU/ US CTAD Task Force  

Combination therapy is expected to play an important role for the treatment of Alzheimer’s disease (AD). In October 2018, the European Union-North American Clinical Trials in Alzheimer’s Disease Task Force (EU/US CTAD Task Force) met to discuss scientific, regulatory, and… Continue Reading →

« Older posts Newer posts »

© 2025 Aging-news